Home / News / CMS assisted Celyad Oncology in the structuring and...

CMS assisted Celyad Oncology in the structuring and implementation of its $ 25 million At The Market offering (ATM)

14/09/2020

CMS Belgium, together with Harvest Law, assisted Celyad Oncology, a Belgian biotech company listed on Euronext Brussels/Paris and on the Nasdaq Global Market, in the structuring and implementation of its $25 million At The Market offering (ATM).

Such an ATM transaction is highly innovative for an European issuer and it will allow Celyad to sell shares from time to time on the Nasdaq market for a period of up to 36 months.

The CMS team was led by Vincent Dirckx in this operation.

Related people

Picture of Vincent Dirckx
Vincent Dirckx
Partner
Brussels